Corneal Flap Transplantation for Macular Hole Repair of High Myopia

Sponsor
First People's Hospital of Hangzhou (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05875909
Collaborator
(none)
30
1
1
46.2
0.6

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to learn about an innovative surgical technique for macular hole repair. This technique is for patients with high myopia using pars plana vitrectomy (PPV) combined with corneal flap transplantation. The main questions it aims to answer are:

  • Is the innovative surgical technique useful for patients?

  • Is the surgical technique safe for patients?

Participants will:
  • Undergo PPV combined with corneal flap transplantation to cover the macular hole.

  • Maintain a prone position for 2 weeks postoperatively.

  • Be observed by visual acuity, slit lamp, optical coherence tomography (OCT) and fundus photography for 1 year after surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: corneal flap transplantation
N/A

Detailed Description

We describe an innovative surgical technique for macular hole repair using pars plana vitrectomy (PPV) combined with corneal flap transplantation. The corneal flap was sealed with autologous blood. The vitreous cavity was then filled with perfluoropropane (C3F8) or sterile air.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Corneal Flap Transplantation for Macular Hole Repair of High Myopia
Actual Study Start Date :
Feb 23, 2022
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: corneal flap transplantation

Patients with macular holes underwent a 25-gauge, 3-port pars plana vitrectomy . Fluid-air exchange was performed in patients with pathologic myopia suffering from macular holes with retinal detachment. We used a flute needle to drain the subretinal fluid. A corneal flap was obtained by small incision lenticule extraction (SMILE). Stripping pliers were applied to spread corneal flap over the macular hole. A drop of fresh autologous whole blood was dripped over the corneal flap to immobilise it. The vitreous cavity was filled with 14% perfluoropropane (C3F8) for macular holes with retinal detachment . The surgical incision was self-closed or sutured with a 6-0 polyglactin 910 suture . The patients were instructed to maintain a prone position for 2 weeks postoperatively.

Procedure: corneal flap transplantation
Patients with macular holes underwent a 25-gauge, 3-port pars plana vitrectomy . Fluid-air exchange was performed in patients with pathologic myopia suffering from macular holes with retinal detachment. We used a flute needle to drain the subretinal fluid. A corneal flap was obtained by small incision lenticule extraction (SMILE). Stripping pliers were applied to spread corneal flap over the macular hole. A drop of fresh autologous whole blood was dripped over the corneal flap to immobilise it. The vitreous cavity was filled with 14% perfluoropropane (C3F8) for macular holes with retinal detachment . The surgical incision was self-closed or sutured with a 6-0 polyglactin 910 suture . The patients were instructed to maintain a prone position for 2 weeks postoperatively.

Outcome Measures

Primary Outcome Measures

  1. best-corrected visual acuity [one month to one year after surgery]

    the best-corrected visual acuity of the patients after surgery

  2. complications [one month to one year after surgery]

    inflammation, infection, rejection reaction, ocular hypertension, ocular hypotension, recrudescent macular hole, parafoveal atrophy, corrugations or irregularities, choroidal neovascularisation, retinal detachment, cystoid macular oedema, reactive pigment epithelial hyperplasia, displacement, or opacification of the corneal flap

  3. closure of the macular holes [one month to one year after surgery]

    closure of the macular holes observed using optical coherence tomography

  4. reattachment of the retina [one month to one year after surgery]

    reattachment of the retina observed using optical coherence tomography

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with macular hole and retinal detachment caused by pathologic myopia.
Exclusion Criteria:
  • Patients with previous retinal surgery, trauma, other ocular diseases that could affect the vision, for example choroidal neovascularization, diabetic retinopathy, or opaque corneas were excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Ophthalmology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China Hangzhou Zhejiang China 310006

Sponsors and Collaborators

  • First People's Hospital of Hangzhou

Investigators

  • Study Chair: Yongping Hu, MD, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
First People's Hospital of Hangzhou
ClinicalTrials.gov Identifier:
NCT05875909
Other Study ID Numbers:
  • 2022-025
First Posted:
May 25, 2023
Last Update Posted:
May 25, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by First People's Hospital of Hangzhou
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 25, 2023